Lantus vs generic: are they the same? — for Spain
Lantus is the originator brand for the active ingredient Insulin Glargine. Once the original patent expired, authorised generic versions of the same active ingredient became available. For most users at 100 IU/mL, the practical question is: is the generic just as good, and what really differs?
Spain context
Authorised generics of Insulin Glargine are typically dispensed in Spain alongside or instead of branded Lantus. Spanish farmacias are typically independent and tightly regulated; the green cross signage marks every authorised pharmacy. Pharmacist consultation is normalised and often the first point of healthcare contact. The pharmacist applies local equivalence rules at the point of dispensing; the brand vs generic price gap in EUR is usually the most decisive economic factor for ongoing use.
- Regulator
- AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
- Currency
- EUR
What is the same
Authorised generics of Insulin Glargine contain the same active substance at the same 100 IU/mL strength as Lantus, with regulator-required bioequivalence to the originator. Clinical effect is, on average, the same. According to the prescribing information, generics meet the same regulatory standard and can substitute for the brand in most patients.
What can differ
Differences include manufacturer, country of production, excipients, tablet appearance, packaging and price. A small minority of patients react to a specific excipient that varies between manufacturers. Price is usually significantly lower for generics — often the most decisive practical difference for chronic use.
Frequently asked questions
Is generic Insulin Glargine as effective as Lantus? ▾
For most users at 100 IU/mL, yes — authorised generics of Insulin Glargine are required to demonstrate bioequivalence to Lantus and produce the same clinical effect on average. Some users notice no difference; a few report subjective differences that are usually due to excipients or expectation.
Why does Lantus cost more than the generic? ▾
The price difference reflects the originator's development costs, brand recognition and marketing, plus the larger volume and competition among generic manufacturers. The active ingredient Insulin Glargine itself is identical between brand and authorised generic at 100 IU/mL.
Lantus vs generic: are they the same? in other countries
- the United StatesFDA (Food and Drug Administration)
- the United KingdomMHRA (Medicines and Healthcare products Regulatory Agency)
- MexicoCOFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios)
- ArgentinaANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica)
- GermanyBfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
- FranceANSM (Agence nationale de sécurité du médicament et des produits de santé)
- ItalyAIFA (Agenzia Italiana del Farmaco)
- BrazilANVISA (Agência Nacional de Vigilância Sanitária)
- CanadaHealth Canada
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.